Report from Extraordinary General Meeting of Minesto AB
GOTHENBURG, Sweden, March 14, 2024 /PRNewswire/ -- An Extraordinary General Meeting in Minesto AB was held today, March 14, 2024, at MAQS Advokatbyrås premises at Östra Hamngatan 24 in Gothenburg. Chairman of the General Meeting was lawyer Eric Ehrencrona from MAQS Advokatbyrå.
The following main resolution was resolved upon at the Extraordinary General Meeting:
Approval of the Board of Directors' resolution on a new issue of units with preferential rights for existing shareholders
The Extraordinary General Meeting resolved to approve the Board of Directors' resolution from 26 February 2024 on a new issue of so-called units, consisting of shares and warrants of series TO4, with preferential rights for existing shareholders.
The complete proposal of the Board of Directors is available on the company's website, www.minesto.com
Please note:
The English text is an uncertified translation and in the event of any inconsistency between the English text and the Swedish text, the Swedish text shall prevail.
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting.
The...
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident.
What Happened?
On March 5, 2024, AD detected it was the...
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...
